Skip to content
thestock.space

Phyto Chem (India) (BSE: PHYTO) is loss-making over the last 12 months, losing ₹2.22 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹17.19, 51% below its 52-week high. Sales fell 30% a year over 3 years. Debt is 4.48× equity. It is a small-cap company with a market cap of ₹7.39 Cr, ranked 70th of 72 Agricultural Inputs companies by market cap; the shares fell 41% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹17.20
Day high
₹17.20
Day low
₹15.51
Prev. close
₹17.00
Volume
742

Health check

6 to check
  • ReturnsBehind

    −40.9% over a year, better than 1 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • GrowthShrinking

    Sales −30.3% a year over 3 years.

  • ProfitabilityNegative

    ROCE -7.9% vs peer median 20.9%.

  • Balance sheetStretched

    Debt 4.48× equity, operating profit doesn’t cover interest, Piotroski 4 of 9.

  • Red flags5 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Agricultural Inputs

71 listed peers. Screen the industry

Small cap

₹7.39 Cr, #70 of 72 in its industry by size.

Defensive

Beta 0.59 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹9 Cr · profit ₹−2 Cr
Market cap
₹7.39 Cr
Small cap
P/E
n/a
Industry 14.4
Price to book
1.62
Peers 4.28
Dividend yield
0.00%
ROE
−32.9%
Peers 16.2%
ROCE
−7.9%
Peers 20.9%
Debt to equity
4.48
Debt ₹20 Cr
EPS (TTM)
−₹5.17
OPM (TTM)
−24.7%
Net margin −23.6%
Sales growth
−98.3%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
0.78
EV/EBITDA −69.8

Strengths and risks

Strengths

  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at −32.9%.
  • Debt is 4.48× equity.
  • Quarterly sales down 98.3% on a year ago.
  • 51% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Phyto Chem (India)

Phyto Chem (India) Limited manufactures and markets pesticides for the agriculture sector in India. It operates through two segments: Pesticides Formulations and Real Estate. The company provides liquid and SC, weedicide, wettable and powder, and granule formulations. It also offers insecticides, synthetic pyrethroids, fungicides, acaricides, antibiotics, and plant growth regulators and promotors. In addition, the company is involved in the real estate…

Headquarters
Hyderabad
Employees
19
Sector
Basic Materials
ISIN
INE037C01010

Price range

52 weeks

₹15.10₹34.99

Today

₹15.51₹17.20
Avg volume (3M)
2.7K
1-year return
minus 40.9%
From 52-week high
minus 50.9%

Peers · Agricultural Inputs

Capital-heavy industry columns

Company
COROMANDELCoromandel International1,824.00minus 4.00%53,72434.517.020.9%9.4%0.1110.2%minus 12.4%
FACTFertilisers and Chemicals Travancore750.25minus 1.24%48,547–703.514.2%0.0%2.950.0%minus 15.3%
UPLUPL534.90plus 1.60%45,21423.96.09.9%20.0%0.83−1.2%minus 28.0%
PIINDPI Industries1,735.00minus 1.98%26,32130.013.114.7%24.2%0.031.1%minus 51.9%
SUMICHEMSumitomo Chemical India328.95plus 0.34%16,41929.421.021.0%20.3%0.02−2.6%minus 34.4%
CHAMBLFERTChambal Fertilizers & Chemicals384.70minus 0.91%15,4138.15.721.8%13.7%0.16−9.2%minus 19.4%
BAYERCROPBayer Cropscience3,316.30plus 0.48%14,90420.015.427.9%16.0%0.033.6%minus 31.7%
PHYTOPhyto Chem (India)17.19plus 1.12%7––−7.9%−24.7%4.48−30.3%minus 40.9%
Median of 7 peers–−0.91%26,32126.615.420.9%16.0%0.110.0%−28.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
1.54.430.20
24.83.20.90.6
−0.5−0.4−0.2−0.7−0.5
−34.2%−10.2%−8.4%−281.9%−2065.7%
0.40.30.30.80
0.30.30.50.40.4
0.10.10.10.10.1
−0.5−0.6−0.5−0.3−0.9
9.1%1.3%1.8%1.9%3.1%
−0.5−0.6−0.5−0.3−0.9
-1.13-1.30-1.13-0.64-2.10

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−30.3%
ROE
−32.9%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
26.814.814.19.1
–minus 44.7%minus 4.9%minus 35.6%
23.91815.210.9
2.9−3.2−1.1−1.8
10.7%−21.7%−7.9%−19.7%
−0.10.10.91.7
2.121.81.5
0.40.30.30.3
−0.12.11.3−0
0.3−3.3−1−1.9
15.9%0.3%5.4%3.7%
0.2−3.3−1−1.8
0.52-7.75-2.31-4.19

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4.34.34.34.3
6.33.12.10.3
19.518.215.820.5
9.96.25.73
4031.727.928.1
2.72.72.42.1
0.10.10.10.1
0.10.200
37.128.725.425.9
4031.727.928.1

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1.43.41.80.9
0.2−0.111.6
−1.7−3.3−2.9−2.6
−0.10.1−0.1−0
−0−0.3−0−0
1.43.11.80.9

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you